The guidance that emerges from CDC's Advisory Committee on Immunization Practices meeting Thursday and Friday could influence whether pharmacists and doctors give vaccines.
SAN ANTONIO — We're approaching three years since COVID-19 reared its ugly head to the world, and we're getting used to living with it. But COVID numbers are once again on the way up. We are in the ...
The pandemic may no longer be a public health emergency, but plenty of my neighbors, friends and family are still having bouts and brushes with COVID-19. Just this past summer, a relative got COVID-19 ...
Workers at San Antonio’s Alamodome vaccination site administer COVID-19 shots during the height of the pandemic. Credit: Courtesy Photo / City of San Antonio In a sign San Antonio’s summer COVID-19 ...
A dwindling COVID-19 vaccine market is not stopping Arcturus Therapeutics from pressing ahead with its own mRNA candidate, as the biotech touts new early data indicating its shot lights up the immune ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of ...
LONDON — The World Health Organization is estimating that nearly 15 million people were killed either by the coronavirus or by its impact on overwhelmed health systems in the past two years, more than ...
Recent weeks have seen successive rises in reported COVID infection numbers across Australia, with figures in some states indicating virus levels not seen since early 2023. The growing wave of COVID, ...
CAPE TOWN - South Africa recorded 566 new Covid-19 cases and 11 more deaths on Wednesday, the National Institute for Communicable Diseases (NICD) said. On Tuesday, the country recorded 136 new ...
SAN ANTONIO - – Across the nation, COVID-19 vaccine sites are reporting lower demand and some vaccine hesitancy, which is causing experts to speak up about misinformation. For months, KSAT has been ...
KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)-- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the results of a follow-up analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results